Strategic Investment Focus Hatteras Venture Partners demonstrates a strong commitment to funding innovative biotech, medtech, and healthtech startups, providing opportunities for suppliers of advanced medical devices, diagnostic tools, and health IT solutions to engage with a venture firm actively seeking scalable innovations.

Emerging Portfolio Companies With recent investments in promising companies like Incyclix Bio, Ten63tx, and Cardiosense, there are opportunities to connect with innovative firms developing cutting-edge therapies and digital health solutions that may require further partnership, technology integration, or commercialization support.

Regional Expansion Potential As a leader in North Carolina and Southeastern U.S. biotech ecosystems, Hatteras offers a gateway to regional health innovation hubs, making it strategic to develop relationships with local service providers, research institutions, and co-investors to access a vibrant network of emerging health tech ventures.

Focus on Growth Funding Hatteras regularly participates in Series A and B financings, signaling opportunities for capital providers, clinical trial support services, and regulatory consultants to engage early in the growth cycle of their portfolio companies, helping scale promising innovations.

Technology-Driven Portfolio With investments in companies leveraging AI, digital health, and innovative medical devices, there’s an opening for technology vendors specializing in AI integration, data analytics, and telehealth platforms to offer tailored solutions that enhance the value proposition of Hatteras-backed companies.